{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,13]],"date-time":"2026-11-13T10:47:01Z","timestamp":1794566821870,"version":"4.9.1"},"reference-count":33,"publisher":"Wiley","issue":"1","license":[{"start":{"date-parts":[[2014,12,18]],"date-time":"2014-12-18T00:00:00Z","timestamp":1418860800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":["onlinelibrary.wiley.com"],"crossmark-restriction":true},"short-container-title":["Br J Haematol"],"published-print":{"date-parts":[[2015,4]]},"abstract":"<jats:title>Summary<\/jats:title>\n                  <jats:p>\n                    Waldenstr\u00f6m macroglobulinaemia (\n                    <jats:styled-content style=\"fixed-case\">WM<\/jats:styled-content>\n                    ) is a rare and incurable lymphoma. Given that the survival of\n                    <jats:styled-content style=\"fixed-case\">WM<\/jats:styled-content>\n                    patients can be prolonged, our objective was to describe trends in overall survival (\n                    <jats:styled-content style=\"fixed-case\">OS<\/jats:styled-content>\n                    ) and analyse competing risks of death in patients with\n                    <jats:styled-content style=\"fixed-case\">WM<\/jats:styled-content>\n                    . The analysis included 5784 patients diagnosed with\n                    <jats:styled-content style=\"fixed-case\">WM<\/jats:styled-content>\n                    between 1991 and 2010 from the\n                    <jats:styled-content style=\"fixed-case\">S<\/jats:styled-content>\n                    urveillance,\n                    <jats:styled-content style=\"fixed-case\">E<\/jats:styled-content>\n                    pidemiology and\n                    <jats:styled-content style=\"fixed-case\">E<\/jats:styled-content>\n                    nd\n                    <jats:styled-content style=\"fixed-case\">R<\/jats:styled-content>\n                    esults (\n                    <jats:styled-content style=\"fixed-case\">SEER<\/jats:styled-content>\n                    ) database. Multivariate hazard models for\n                    <jats:styled-content style=\"fixed-case\">OS<\/jats:styled-content>\n                    and cumulative incidence of death were fitted according to epoch of diagnosis (1991\u20132000 vs. 2001\u201310) while adjusting for age, sex, race, histology, site of involvement and registry. Median\n                    <jats:styled-content style=\"fixed-case\">OS<\/jats:styled-content>\n                    for the 1991\u20132000 and the 2001\u201310 cohorts was 6 and 8\u00a0years, respectively (\n                    <jats:italic>P<\/jats:italic>\n                    \u00a0&lt;\u00a00\u00b7001). In the multivariate analysis, better\n                    <jats:styled-content style=\"fixed-case\">OS<\/jats:styled-content>\n                    [hazard ratio (\n                    <jats:styled-content style=\"fixed-case\">HR<\/jats:styled-content>\n                    ) 0\u00b773, 95% confidence interval (\n                    <jats:styled-content style=\"fixed-case\">CI<\/jats:styled-content>\n                    ) 0\u00b767\u20130\u00b779;\n                    <jats:italic>P<\/jats:italic>\n                    \u00a0&lt;\u00a00\u00b7001] was seen in the 2001\u201310 cohort. Survival benefits were identified, for the 2001\u201310 cohort, in almost every stratum analysed, with the exception of patients aged &lt;50\u00a0years and blacks. In the multivariate competing\u2010risk analysis, the 2001\u201310 cohort experienced lower rates of\n                    <jats:styled-content style=\"fixed-case\">WM<\/jats:styled-content>\n                    \u2010related (\n                    <jats:styled-content style=\"fixed-case\">HR<\/jats:styled-content>\n                    0\u00b757, 95%\n                    <jats:styled-content style=\"fixed-case\">CI<\/jats:styled-content>\n                    0\u00b749\u20130\u00b766;\n                    <jats:italic>P<\/jats:italic>\n                    \u00a0&lt;\u00a00\u00b7001) and non\u2010\n                    <jats:styled-content style=\"fixed-case\">WM<\/jats:styled-content>\n                    \u2010related deaths (\n                    <jats:styled-content style=\"fixed-case\">HR<\/jats:styled-content>\n                    0\u00b772, 95%\n                    <jats:styled-content style=\"fixed-case\">CI<\/jats:styled-content>\n                    0\u00b766\u20130\u00b779;\n                    <jats:italic>P<\/jats:italic>\n                    \u00a0&lt;\u00a00\u00b7001). In conclusion, there have been significant improvements in\n                    <jats:styled-content style=\"fixed-case\">OS<\/jats:styled-content>\n                    ,\n                    <jats:styled-content style=\"fixed-case\">WM<\/jats:styled-content>\n                    \u2010related and non\u2010\n                    <jats:styled-content style=\"fixed-case\">WM<\/jats:styled-content>\n                    \u2010related mortality in patients with\n                    <jats:styled-content style=\"fixed-case\">WM<\/jats:styled-content>\n                    diagnosed in the last decade.\n                  <\/jats:p>","DOI":"10.1111\/bjh.13264","type":"journal-article","created":{"date-parts":[[2014,12,19]],"date-time":"2014-12-19T01:49:48Z","timestamp":1418953788000},"page":"81-89","update-policy":"https:\/\/doi.org\/10.1002\/crossmark_policy","source":"Crossref","is-referenced-by-count":120,"title":["Overall survival and competing risks of death in patients with\u00a0\n                    <scp>W<\/scp>\n                    aldenstr\u00f6m macroglobulinaemia: an analysis of the\n                    <scp>S<\/scp>\n                    urveillance,\n                    <scp>E<\/scp>\n                    pidemiology and\n                    <scp>E<\/scp>\n                    nd\n                    <scp>R<\/scp>\n                    esults database"],"prefix":"10.1111","volume":"169","author":[{"given":"Jorge J.","family":"Castillo","sequence":"first","affiliation":[{"name":"Bing Center for Waldenstr\u00f6m Macroglobulinemia Dana\u2010Farber Cancer Institute Boston MA USA"},{"name":"Department of Medicine Harvard Medical School Boston MA USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Adam J.","family":"Olszewski","sequence":"additional","affiliation":[{"name":"Division of Hematology and Oncology Memorial Hospital of Rhode Island The Warren Alpert Medical School of Brown University Pawtucket RI USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sandra","family":"Kanan","sequence":"additional","affiliation":[{"name":"Bing Center for Waldenstr\u00f6m Macroglobulinemia Dana\u2010Farber Cancer Institute Boston MA USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kirsten","family":"Meid","sequence":"additional","affiliation":[{"name":"Bing Center for Waldenstr\u00f6m Macroglobulinemia Dana\u2010Farber Cancer Institute Boston MA USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zachary R.","family":"Hunter","sequence":"additional","affiliation":[{"name":"Bing Center for Waldenstr\u00f6m Macroglobulinemia Dana\u2010Farber Cancer Institute Boston MA USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Steven P.","family":"Treon","sequence":"additional","affiliation":[{"name":"Bing Center for Waldenstr\u00f6m Macroglobulinemia Dana\u2010Farber Cancer Institute Boston MA USA"},{"name":"Department of Medicine Harvard Medical School Boston MA USA"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2014,12,18]]},"reference":[{"key":"e_1_2_9_2_1","doi-asserted-by":"publisher","DOI":"10.1159\/000360992"},{"key":"e_1_2_9_3_1","first-page":"1","article-title":"United States life tables, 2010","volume":"63","author":"Arias E.","year":"2014","journal-title":"National Vital Statistics Reports"},{"key":"e_1_2_9_4_1","doi-asserted-by":"publisher","DOI":"10.1038\/leu.2008.261"},{"key":"e_1_2_9_5_1","doi-asserted-by":"publisher","DOI":"10.1002\/cncr.28264"},{"key":"e_1_2_9_6_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2014-05-574871"},{"key":"e_1_2_9_7_1","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1111\/j.2517-6161.1972.tb00899.x","article-title":"Regression models and life tables (with discussion)","volume":"34","author":"Cox D.","year":"1972","journal-title":"Journal of the Royal Statistical Society B"},{"key":"e_1_2_9_8_1","doi-asserted-by":"publisher","DOI":"10.1080\/01621459.1999.10474144"},{"key":"e_1_2_9_9_1","doi-asserted-by":"publisher","DOI":"10.1158\/1055-9965.EPI-12-0466"},{"key":"e_1_2_9_10_1","doi-asserted-by":"publisher","DOI":"10.3109\/10428194.2012.708751"},{"key":"e_1_2_9_11_1","doi-asserted-by":"crossref","first-page":"1361","DOI":"10.1182\/blood.V84.5.1361.1361","article-title":"A revised European\u2010 American classification of lymphoid neoplasms: a proposal from the International Lymphoma Study Group","volume":"84","author":"Harris N.L.","year":"1994","journal-title":"Blood"},{"key":"e_1_2_9_12_1","unstructured":"2001 IARC Lyon E.S. Jaffe N.L. Harris H. Stein J.W. Vardiman World Health Organization Classification of Tumours: Pathology and Genetics of Tumours of Haematopoietic and Lymphoid Tissues"},{"key":"e_1_2_9_13_1","doi-asserted-by":"publisher","DOI":"10.1080\/01621459.1958.10501452"},{"key":"e_1_2_9_14_1","doi-asserted-by":"publisher","DOI":"10.1002\/ajh.22027"},{"key":"e_1_2_9_15_1","doi-asserted-by":"publisher","DOI":"10.1002\/ajh.23351"},{"key":"e_1_2_9_16_1","doi-asserted-by":"publisher","DOI":"10.1038\/leu.2009.134"},{"key":"e_1_2_9_17_1","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2012.44.7920"},{"key":"e_1_2_9_18_1","doi-asserted-by":"publisher","DOI":"10.1002\/ajh.20724"},{"key":"e_1_2_9_19_1","first-page":"163","article-title":"Evaluation of survival data and two new rank order statistics arising in its consideration","volume":"50","author":"Mantel N.","year":"1966","journal-title":"Cancer Chemotherapy Reports"},{"key":"e_1_2_9_20_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2008-08-174961"},{"key":"e_1_2_9_21_1","doi-asserted-by":"crossref","first-page":"1144","DOI":"10.1182\/blood.V85.4.1144.bloodjournal8541144","article-title":"Monoclonal gammopathies and hepatitis C virus infection","volume":"85","author":"Mussini C.","year":"1995","journal-title":"Blood"},{"key":"e_1_2_9_22_1","doi-asserted-by":"publisher","DOI":"10.1002\/ajh.23708"},{"key":"e_1_2_9_23_1","doi-asserted-by":"publisher","DOI":"10.3109\/10428194.2014.898758"},{"key":"e_1_2_9_24_1","doi-asserted-by":"publisher","DOI":"10.3816\/CLM.2005.n.006"},{"key":"e_1_2_9_25_1","doi-asserted-by":"publisher","DOI":"10.3109\/10428194.2012.656103"},{"key":"e_1_2_9_26_1","doi-asserted-by":"publisher","DOI":"10.1155\/2011\/725219"},{"key":"e_1_2_9_27_1","doi-asserted-by":"publisher","DOI":"10.1002\/cncr.25765"},{"key":"e_1_2_9_28_1","first-page":"194","volume-title":"WHO Classification of Tumours of Haematopoietic and Lymphoid Tissues","author":"Swerdlow S.H.","year":"2008"},{"key":"e_1_2_9_29_1","doi-asserted-by":"publisher","DOI":"10.1002\/1097-0142(19820515)49:10<2112::AID-CNCR2820491024>3.0.CO;2-2"},{"key":"e_1_2_9_30_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2009-05-174359"},{"key":"e_1_2_9_31_1","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2008.20.4677"},{"key":"e_1_2_9_32_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1200710"},{"key":"e_1_2_9_33_1","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1182\/blood.V122.21.251.251","article-title":"A prospective multicenter study of the Bruton's tyrosine kinase inhibitor ibrutinib in patients with relapsed or refractory Waldenstrom's macroglobulinemia","volume":"122","author":"Treon S.P.","year":"2013","journal-title":"Blood"},{"key":"e_1_2_9_34_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2014-03-566273"}],"container-title":["British Journal of Haematology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fbjh.13264","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/bjh.13264","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,6,5]],"date-time":"2024-06-05T19:37:24Z","timestamp":1717616244000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1111\/bjh.13264"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,12,18]]},"references-count":33,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2015,4]]}},"alternative-id":["10.1111\/bjh.13264"],"URL":"https:\/\/doi.org\/10.1111\/bjh.13264","archive":["Portico"],"relation":{},"ISSN":["0007-1048","1365-2141"],"issn-type":[{"value":"0007-1048","type":"print"},{"value":"1365-2141","type":"electronic"}],"subject":[],"published":{"date-parts":[[2014,12,18]]},"assertion":[{"value":"2014-10-14","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2014-11-17","order":1,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2014-12-18","order":2,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}